PCMA believes that the recommendations made by the board lacked thorough understanding of the impact of PET packaging on medicinal products, as PET is a legally and globally accepted packaging material. They have requested the concerned authorities of departments to consider every aspect of this issue, the regulatory practices and good manufacturing practice (GMP) standards while taking a final decision on this matter. IGMPI
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…